Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A3309 (Elobixibat) in Dyslipidemia
NCT01069783Phase 2Completed
- Sponsor
- Albireo Pharma
- Start
- Feb 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elobixibat in dyslipidemia, sponsored by Albireo Pharma. Started Feb 2010; status: completed.
02
Drugs
elobixibat
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01069783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069783.